[go: up one dir, main page]

PL3787667T3 - Kompozycja do kontrolowanej stymulacji jajników - Google Patents

Kompozycja do kontrolowanej stymulacji jajników

Info

Publication number
PL3787667T3
PL3787667T3 PL19722535.2T PL19722535T PL3787667T3 PL 3787667 T3 PL3787667 T3 PL 3787667T3 PL 19722535 T PL19722535 T PL 19722535T PL 3787667 T3 PL3787667 T3 PL 3787667T3
Authority
PL
Poland
Prior art keywords
composition
ovarian stimulation
controlled ovarian
controlled
stimulation
Prior art date
Application number
PL19722535.2T
Other languages
English (en)
Inventor
Ian Cottingham
Original Assignee
Ferring B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring B.V. filed Critical Ferring B.V.
Publication of PL3787667T3 publication Critical patent/PL3787667T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
PL19722535.2T 2018-04-30 2019-04-25 Kompozycja do kontrolowanej stymulacji jajników PL3787667T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP18170138 2018-04-30
EP18172725 2018-05-16
EP19152465 2019-01-18
PCT/EP2019/060577 WO2019211153A1 (en) 2018-04-30 2019-04-25 Composition for controlled ovarian stimulation

Publications (1)

Publication Number Publication Date
PL3787667T3 true PL3787667T3 (pl) 2025-07-28

Family

ID=66440004

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19722535.2T PL3787667T3 (pl) 2018-04-30 2019-04-25 Kompozycja do kontrolowanej stymulacji jajników

Country Status (15)

Country Link
US (2) US20210038694A1 (pl)
EP (2) EP3787667B1 (pl)
JP (2) JP2021522268A (pl)
CN (1) CN112088011A (pl)
DK (1) DK3787667T3 (pl)
ES (1) ES3029733T3 (pl)
FI (1) FI3787667T3 (pl)
HR (1) HRP20250452T1 (pl)
HU (1) HUE071268T2 (pl)
LT (1) LT3787667T (pl)
PL (1) PL3787667T3 (pl)
RS (1) RS66871B1 (pl)
SI (1) SI3787667T1 (pl)
TW (1) TW201945024A (pl)
WO (1) WO2019211153A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6856819B2 (ja) 2017-09-01 2021-04-14 フェリング ベスローテン フェンノートシャップ 調節卵巣刺激のための組成物
TWI846743B (zh) 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
TW202210096A (zh) * 2020-05-29 2022-03-16 荷蘭商菲林公司 治療不育症之方法
TW202237173A (zh) * 2020-12-09 2022-10-01 荷蘭商菲林公司 用於受控的卵巢刺激之組成物及方法
AU2022451605A1 (en) * 2022-04-01 2024-09-26 Ferring B.V. Mixed protocol for treatment of infertility
AU2023275943A1 (en) * 2022-05-26 2024-10-17 Ferring B.V. Compositions and methods for treatment of infertility in males
WO2025149590A1 (en) * 2024-01-09 2025-07-17 Ferring B.V. Compositions and methods for controlled ovarian stimulation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2850980B1 (fr) 2003-02-06 2005-04-15 Afssa Sequences specifiques d'e. coli 0145, et leurs utilisations
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
TWI488640B (zh) 2008-04-16 2015-06-21 Ferring Int Ct Sa 藥學製劑
TWI604850B (zh) * 2009-10-05 2017-11-11 菲瑞茵國際中心股份有限公司 藥學製劑
SI2621517T2 (sl) * 2010-09-29 2023-11-30 Ferring B.V. Sestavek za uporabo pri zdravljenju neplodnosti
WO2012127501A2 (en) * 2011-03-11 2012-09-27 Sanzyme Limited Composition for improving endometrial thickness during ovarian stimulation
KR20140053991A (ko) * 2011-07-18 2014-05-08 아츠 바이올로직스 에이/에스 장기간 작용하는 황체 형성 호르몬 (lh) 화합물
JO3092B1 (ar) * 2011-08-08 2017-03-15 Ferring Bv مركب لتحفيز مسيطر عليه للمبيض
EP3283097B1 (en) * 2015-04-17 2020-02-12 Ferring B.V. Fsh for treatment of infertility
AU2016251314B2 (en) 2015-04-24 2019-12-05 Ferring B.V. Method of production of gonadotrophin

Also Published As

Publication number Publication date
EP3787667A1 (en) 2021-03-10
TW201945024A (zh) 2019-12-01
EP4534145A2 (en) 2025-04-09
WO2019211153A1 (en) 2019-11-07
HUE071268T2 (hu) 2025-08-28
EP4534145A3 (en) 2025-07-02
HRP20250452T1 (hr) 2025-06-06
JP2021522268A (ja) 2021-08-30
FI3787667T3 (fi) 2025-07-04
RS66871B1 (sr) 2025-06-30
DK3787667T3 (da) 2025-06-16
ES3029733T3 (en) 2025-06-25
EP3787667B1 (en) 2025-03-26
CN112088011A (zh) 2020-12-15
US20210038694A1 (en) 2021-02-11
US20250114434A1 (en) 2025-04-10
SI3787667T1 (sl) 2025-06-30
JP2024056722A (ja) 2024-04-23
LT3787667T (lt) 2025-05-12

Similar Documents

Publication Publication Date Title
LT3787667T (lt) Kompozicija, skirta kontroliuojamam kiaušidžių stimuliavimui
GB201810492D0 (en) Composition
GB201811100D0 (en) Composition
GB201812145D0 (en) Composition
GB201804434D0 (en) Composition
IL280750A (en) Ingredients and methods for controlled ovarian stimulation
IL272763A (en) The composition for controlled stimulation of the ovary
GB201818827D0 (en) Composition
GB201815031D0 (en) Composition
GB201801596D0 (en) Composition
GB201810024D0 (en) Composition
PT3866833T (pt) Composições compreendendo uma fsh recombinante para o tratamento da infertilidade
HK40115814A (en) Composition for controlled ovarian stimulation
PT3787667T (pt) Composição para estimulação controlada do ovário
GB201819861D0 (en) Composition
GB201815032D0 (en) Composition
GB201809123D0 (en) Composition
HK40021791A (en) Composition for controlled ovarian stimulation
ZA202100281B (en) Water-in-oil coating composition
ZA202100065B (en) Water-in-oil coating composition
GB201818567D0 (en) Composition
GB201815704D0 (en) Composition
GB201815165D0 (en) Composition
GB201813442D0 (en) Composition
GB201811889D0 (en) Composition